ArticleNeurology2022

Reader Response: Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis.

Harald Kropshofer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.